remsima

Biosimilars – NICE resource to support the implementation of biosimilar versions of infliximab

NICE has published a new adoption resource to support the introduction of biosimilar versions of infliximab: Inflectra and Remsima. This resource has been developed for both clinicians and non-clinical staff to help manage the introduction of these biosimilar medicines into care pathways safely and effectively.